Risk of Ptosis following Glaucoma Tube Shunt Placement

Overview

About this study

The prupose of this study is to determine the incidence and amount of ptosis after tube shunt placement compared to other types of anterior segment surgery.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Adult patients undergoing anterior segment surgery including single Ahmed or Baerveldt tube shunt placement, trabeculectomy, or cataract surgery Mayo Clinic Rochester. 

Exclusion Criteria:            

  • Patients <18 years old
  • Previous scleral buckle
  • Boston keratoprosthesis
  • Thyroid eye disease
  • Previous eyelid surgery
  • History of subtenon’s steroid injection

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

Cheryl Khanna, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Additional contact information

Non-cancer trials contact form

Phone: 800-664-4542 (toll-free)

International patient clinical studies questions